Coluracetam
Suzhou MyLand Pharm&Nutrition Inc,Mainly engaged in the development and production of healthy nutrition, with over 20 years of industry experience, first developed in China in 1992 grape seed...
Компания: | Suzhou MyLand Pharm&Nutrition Inc. |
Артикул: | 135463-81-9 |
Цена: | 5113,35 $ |
Город: | Suzhou |
Категория: | Фармацевтические препараты |
Classification: Other Chemicals
Cas NO.: 135463-81-9
Molecular Formula: C19H23N3O3
Melting Point:
Boiling Point: 634.1°C at 760 mmHg
Stability: null
Refractive index:1.64
Flash Point: 337.3°C
Purity: 99
Appearance: null
usage: a nootropic drug of the racetam family
Brand Name: myland
EINECS: 1308068-626-2
Aliase: N-(2,3-Dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide.
Purity: 99
Appearance:white crystalline powder
Brand: myland
Packaging & Delivery
Packaging Detail: 1kg/bag.
Delivery Detail:
Detailed Description
Product name:Coluracetam
Chemical name: N-(2,3-Dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide.
CAS:135463-81-9
Purity: 99%
Appearance: white crystalline powder
Package: 1kg/bag.
Coluracetam (BCI-540) is a nootropic drug of the racetam family.Coluracetam (formerly known as MKC-231) was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer's disease. After the drug failed to reach endpoints in its clinical trials it was in-licensed by BrainCells Inc for investigations into major depression disorder (MDD), after being awarded a "Qualifying Therapeutic Discovery Program Grant" by the state of California.Findings from its Phase 2a clinical trials have suggested that it would be an ideal medication for co-morbid MDD with generalized anxiety disorder (GAD).BrainCells Inc is currently out-licensing the drug for this purpose.It may also have potential use in prevention and treatment of ischemic retinopathy and retinal and optic nerve injury.
Coluracetam enhances high-affinity choline uptake (HACU) which is the rate-limiting step of acetylcholine (ACh) synthesis, and is the only known choline uptake enhancer to currently exist. Studies have shown Coluracetam to improve learning impairment on a single oral dose given to rats which have been exposed to cholinergic neurotoxins. Subsequent studies have shown that it may induce long-lasting procognitive effects by changing the choline transporter regulation system.